Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis b Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03018821
What this trial is testing

The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B

Who this might be right for
Hepatitis B， Chronic
Xi'an Traditional Medicine Hospital 250
Large-scale testing (Phase 3)Ended earlyNCT00221286
What this trial is testing

Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

Who this might be right for
Chronic Hepatitis BHIV Infections
University Hospital, Bonn 2
Post-approval studies (Phase 4)Study completedNCT00614471
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 219
Post-approval studies (Phase 4)Study completedNCT01639092
What this trial is testing

Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B

Who this might be right for
Chronic Viral Hepatitis B Without Delta-agent
Asan Medical Center 88
Not applicableStudy completedNCT00973219
What this trial is testing

Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load

Who this might be right for
Chronic Hepatitis B
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 151
Testing effectiveness (Phase 2)UnknownNCT06566248
What this trial is testing

A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90
Post-approval studies (Phase 4)Ended earlyNCT00460850
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 60
Testing effectiveness (Phase 2)Looking for participantsNCT06263959
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Fujian Akeylink Biotechnology Co., Ltd. 45
Testing effectiveness (Phase 2)Study completedNCT07364448
What this trial is testing

Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis

Who this might be right for
Chronic Hepatitis B With Hepatic Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 411
Post-approval studies (Phase 4)UnknownNCT02745704
What this trial is testing

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Not applicableUnknownNCT03435406
What this trial is testing

Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China

Who this might be right for
Hepatopulmonary Syndrome
Southwest Hospital, China 300
Post-approval studies (Phase 4)Study completedNCT00962533
What this trial is testing

EFFicacy Optimization Research of Telbivudine Therapy

Who this might be right for
Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University 606
Large-scale testing (Phase 3)Study completedNCT01697501
What this trial is testing

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 88
Not applicableNot Yet RecruitingNCT07481032
What this trial is testing

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

Who this might be right for
Cirrhosis, LiverHepatocellular Carcinoma (HCC)HEPATITIS B CHRONIC
Nanfang Hospital, Southern Medical University 1,034
Not applicableUnknownNCT05293158
What this trial is testing

Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study

Who this might be right for
Hepatocellular CarcinomaHBV
Medical University of Graz 5
Post-approval studies (Phase 4)UnknownNCT03208998
What this trial is testing

The Changes of Natural Killer Cells Frequency and Function During Antiviral Therapy

Who this might be right for
Chronic Hepatitis B Infection
Beijing Ditan Hospital 100
Not applicableUnknownNCT03733652
What this trial is testing

Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis bEfficacy, Self
Third Affiliated Hospital, Sun Yat-Sen University 100
Large-scale testing (Phase 3)UnknownNCT02805738
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet

Who this might be right for
Chronic Hepatitis B
Chong Kun Dang Pharmaceutical 158
Large-scale testing (Phase 3)Looking for participantsNCT07606950
What this trial is testing

Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B

Who this might be right for
Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
Fujian Shengdi Pharmaceutical Co., Ltd. 540
Post-approval studies (Phase 4)Active Not RecruitingNCT03753074
What this trial is testing

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

Who this might be right for
Chronic Hepatitis b
Young-Suk Lim 780
Next Page